Lab. Giovanna CHIMINI
AN INTERNATIONAL INNOVATOR
From identifying the complexity of the mammalian lipid ABC transporters and their role in immunity to developing BIOTRAIL, the AMIDEX international interdisciplinary program in Life Sciences, the pioneer Giovanna Chimini has been a team leader at the CIML from 1992 to 2010 and is now Associate Dean in charge of Research and International Relations at the Faculty of Sciences, Aix-Marseille University.
Balan S. et al., Cell Reports, 2018
The team of Marc DALOD, CNRS Team Leader at the Centre d'Immunologie de Marseille-Luminy, CNRS, Inserm and Aix-Marseille University, in collaboration with a team from "The Tisch Cancer Institute", Icahn School of Medicine at Mount Sinai in New York, has found a way to artificially generate a type of immune cell that could help make dendritic cell vaccines, a promising type of immunotherapy, more effective. This study is published in Cell Reports on August 14, 2018.
Mount Sinai
Researchers Artificially Generate Immune Cells Integral To Creating Cancer Vaccines
More
ResearchGate
Immune cell type best suited for cancer vaccines can now be grown in the lab
New approach paves the way to making dendritic cell vaccines more effective.
Researchers have found a way to artificially generate a type of immune cell that could help make dendritic cell vaccines, a promising type of immunotherapy, more effective... Marc Dalod Interview
